​
​

Longboard Pharmaceuticals Ownership | Who Owns Longboard Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Longboard Pharmaceuticals Ownership Summary

Longboard Pharmaceuticals is owned by 99.80% institutional investors, 1.30% insiders. Fmr is the largest institutional shareholder, holding 11.36% of LBPH shares. Fidelity Select Biotechnology is the top mutual fund, with 4.38% of its assets in Longboard Pharmaceuticals shares.

LBPH Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockLongboard Pharmaceuticals99.80%1.30%-1.10%
SectorHealthcare Stocks 47.06%8.01%44.93%
IndustryBiotech Stocks 44.97%7.82%47.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr4.42M11.36%$119.34M
Farallon capital management2.94M7.56%$79.48M
Cormorant asset management, lp2.79M7.18%$75.43M
Price t rowe associates inc /md/2.51M6.45%$67.81M
Blackrock2.37M6.09%$64.02M
Vanguard group1.93M4.95%$52.04M
Wellington management group llp1.78M4.58%$48.09M
Viking global investors lp1.66M4.27%$44.84M
Polar capital1.35M3.48%$36.61M
Integral health asset management1.10M2.83%$29.73M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cormorant asset management, lp2.79M4.36%$75.43M
Nan fung group144.57K4.17%$3.91M
Ally bridge group (ny)218.98K3.53%$5.92M
Integral health asset management1.10M2.82%$29.73M
Parkman healthcare partners694.18K2.51%$18.76M
Silverarc capital management122.85K0.78%$3.32M
Saturn v capital management71.44K0.73%$1.93M
Farallon capital management2.94M0.38%$79.48M
Emerald mutual fund advisers trust183.58K0.26%$4.96M
Emerald advisers228.52K0.26%$6.18M

Top Buyers

HolderShares% AssetsChange
Viking global investors lp1.66M0.17%677.63K
Blackrock2.37M0.00%502.16K
Pictet asset management sa913.78K0.03%337.11K
Price t rowe associates inc /md/2.51M0.01%290.54K
Emerald advisers228.52K0.26%228.52K

Top Sellers

HolderShares% AssetsChange
Ra capital management---3.29M
Point72 asset management---1.03M
Cormorant asset management, lp2.79M4.36%-562.68K
Wellington management group llp1.78M0.01%-357.39K
Alyeska investment group---212.88K

New Positions

HolderShares% AssetsChangeValue
Emerald advisers228.52K0.26%228.52K$6.18M
Candriam s.c.a.225.92K0.04%225.92K$6.11M
Emerald mutual fund advisers trust183.58K0.26%183.58K$4.96M
Silverarc capital management122.85K0.78%122.85K$3.32M
Saturn v capital management71.44K0.73%71.44K$1.93M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-2.00
Lifesteps financial-200.00
Ikarian capital-236.00
Metropolitan life insurance co/ny-1.36K
Point72 (difc)-1.57K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2024101-6.48%38,802,3832.38%990.87%67-27.96%28250.00%
Mar 31, 2024108107.69%37,901,255129.32%1072.25%93210.00%8-20.00%
Dec 31, 2023521.96%16,527,8975.54%691.55%3025.00%10-28.57%
Sep 30, 2023512.00%15,660,4367.73%661.66%24-41.46%14133.33%
Jun 30, 202350100.00%14,536,38410.21%631.52%4186.36%6200.00%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Select Biotechnology1.71M4.38%-
T. Rowe Price Health Sciences1.11M2.85%-10.79K
Vanguard Total Stock Mkt Idx Inv1.09M2.80%-3.71K
Polar Capital Biotech S Inc1.00M2.56%-
T. Rowe Price New Horizons901.56K2.32%-2.84K
US Small-Cap Growth II Equity Comp901.56K2.32%30.99K
Fidelity Global Innovators Cl F842.55K2.17%-3.53K
iShares Russell 2000 ETF831.97K2.13%-1.88K
Pictet-Biotech P USD532.43K1.36%-2.93K
Fidelity Series Small Cap Opps499.80K1.28%-21.70K

Recent Insider Transactions

DateNameRoleActivityValue
Oct 15, 2024Kaye Randall CMOSell$983.94K
Sep 16, 2024Kaye Randall CMOSell$133.62K
Sep 16, 2024Kaye Randall CMOSell$39.75K
Sep 16, 2024Kaye Randall CMOSell$64.67K
Sep 16, 2024Kaye Randall CMOSell$289.28K

Insider Transactions Trends

DateBuySell
2024 Q4-1
2024 Q3-6
2024 Q2-1
2024 Q111
2023 Q2--

LBPH Ownership FAQ

Who Owns Longboard Pharmaceuticals?

Longboard Pharmaceuticals shareholders are primarily institutional investors at 99.80%, followed by 1.30% insiders and -1.10% retail investors. The average institutional ownership in Longboard Pharmaceuticals's industry, Biotech Stocks , is 44.97%, which Longboard Pharmaceuticals exceeds.

Who owns the most shares of Longboard Pharmaceuticals?

Longboard Pharmaceuticals’s largest shareholders are Fmr (4.42M shares, 11.36%), Farallon capital management (2.94M shares, 7.56%), and Cormorant asset management, lp (2.79M shares, 7.18%). Together, they hold 26.10% of Longboard Pharmaceuticals’s total shares outstanding.

Does Blackrock own Longboard Pharmaceuticals?

Yes, BlackRock owns 6.09% of Longboard Pharmaceuticals, totaling 2.37M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 64.02M$. In the last quarter, BlackRock increased its holdings by 502.16K shares, a 26.91% change.

Who is Longboard Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Cormorant asset management, lp is Longboard Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.36% of its assets in 2.79M Longboard Pharmaceuticals shares, valued at 75.43M$.

Who is the top mutual fund holder of Longboard Pharmaceuticals shares?

Fidelity Select Biotechnology is the top mutual fund holder of Longboard Pharmaceuticals shares, with 4.38% of its total shares outstanding invested in 1.71M Longboard Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools